oral glp-1 agonist analogue: perspectives and impact on atherosclerosis in type 2 diabetic patients | Cardiovascular Diabetology Orforglipron, an Oral Small-Molecule GLP-1
Description
doi: 10.1111/dom.12601

Konig M, Riddle MC, Colhoun HM, et al

J Diabetes its Complications (2017) 31(9):13705

[DOI] [PubMed] [Google Scholar] 416.Wilmen A., Goke B., Goke R

practicing mindful eating
